Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug elimination interactions: analysis using a mathematical model.

R H Luecke, W D Wosilait

    Journal of Pharmacokinetics and Biopharmaceutics
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data.

    Journal of toxicology and environmental health. Part A·2001
    Same author

    Mathematical modeling of human embryonic and fetal growth rates.

    Growth, development, and aging : GDA·2000
    Same author

    Physiological "constants" for PBPK models for pregnancy.

    Journal of toxicology and environmental health·1997
    Same author

    A computer model and program for xenobiotic disposition during pregnancy.

    Computer methods and programs in biomedicine·1997
    Same author

    Mathematical analysis for teratogenic sensitivity.

    Teratology·1997
    Same author

    Mathematical representation of organ growth in the human embryo/fetus.

    International journal of bio-medical computing·1995
    Same journal

    Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

    Journal of pharmacokinetics and biopharmaceutics·2010
    Same journal

    Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

    Journal of pharmacokinetics and biopharmaceutics·2010
    Same journal

    Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

    Journal of pharmacokinetics and biopharmaceutics·2010
    Same journal

    Pharmacokinetics of methotrexate in solid tumors.

    Journal of pharmacokinetics and biopharmaceutics·2010
    Same journal

    Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

    Journal of pharmacokinetics and biopharmaceutics·2010
    Same journal

    Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

    Journal of pharmacokinetics and biopharmaceutics·2010
    See all related articles

    This study introduces a mathematical model to predict drug interactions in rats by analyzing elimination kinetics. The model accurately simulates acute warfarin-BSP interactions, aiding in understanding complex pharmacokinetic behaviors.

    Area of Science:

    • Pharmacokinetics and Drug Metabolism
    • Mathematical Modeling in Biology
    • Toxicology and Pharmacology

    Background:

    • Drug interactions can alter elimination kinetics, impacting efficacy and safety.
    • Understanding these interactions is crucial for predicting drug behavior in vivo.
    • Previous models may not fully capture the complexity of enzymatic processes and competitive inhibition.

    Purpose of the Study:

    • To develop a physiologically-based mathematical model for analyzing drug elimination kinetics.
    • To incorporate Michaelis-Menten kinetics and competitive inhibition into the model.
    • To simulate and predict the outcomes of acute drug-drug interactions in rats.

    Main Methods:

    • Developed a mathematical model integrating physiological parameters (blood flow, organ weights).

    Related Experiment Videos

  • Utilized Michaelis-Menten equations to represent enzymatic drug elimination.
  • Modeled competitive inhibition for drugs sharing metabolic pathways.
  • Validated the model using data from single drug administrations to simulate warfarin-BSP interactions.
  • Main Results:

    • The model successfully simulates drug elimination kinetics based on physiological data.
    • It accurately predicts the outcomes of acute warfarin-BSP interactions in rats.
    • The model demonstrates the impact of competitive inhibition on drug clearance.

    Conclusions:

    • A robust mathematical model for drug interaction analysis has been established.
    • The model provides a valuable tool for predicting pharmacokinetic interactions in vivo.
    • This approach enhances the understanding of drug metabolism and competitive inhibition mechanisms.